UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Author | Type
Jump to: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | V | W | Y | Z
Number of items: 336.

A

Adams, MJ; Cardigan, RA; Marchant, WA; Grocott, MPW; Mythen, MG; Mutch, M; Purdy, G; (2002) Tissue factor pathway inhibitor antigen and activity in 96 patients receiving heparin for cardiopulmonary bypass. J CARDIOTHOR VASC AN , 16 (1) 59 - 63. 10.1053/jcan.2002.29677.

Ala, A; Standish, R; Khan, K; Hillan, K; Dhillon, A; Hodgson, H; (2002) Podoplanin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) localisation in primary sclerosing cholangitis (PSC) and primary biliary cirrhosis (PBC). Journal of Hepatology , 36 501-.

Ala, A; Standish, R; Khan, K; Stubbs, M; Hillan, K; Dhillon, AP; Hodgson, HJF; (2002) Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and podoplanin localisation in primary sclerosing cholangitis (PSC) & primary biliary cirrhosis (PBC). Gut , 50 202-.

Ala, A; Standish, R; Khan, K; Stubbs, M; Hillan, K; Dhillon, AP; Hodgson, HJF; (2002) Mucosal addressin cell adhesion molecule-1 (MAdCAM-1) and podoplanin localisation in primary sclerosing cholangitis (PSC) & primary biliary cirrhosis (PBC). GUT , 50 A56 - A56.

Aligianis, IA; Forshew, T; Johnson, S; Michaelides, M; Johnson, CA; Trembath, RC; Hunt, DM; (2002) Mapping of a novel locus for achromatopsia (ACHM4) to 1p and identification of a germline mutation in the alpha subunit of cone transducin (GNAT2). J MED GENET , 39 (9) 656 - 660.

Allcock, RJN; Atrazhev, AM; Beck, S; de Jong, PJ; Elliott, JF; Forbes, S; Halls, K; (2002) The MHC haplotype project: A resource for HLA-linked association studies. TISSUE ANTIGENS , 59 (6) 520 - 521.

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. Blood , 100 (2) pp. 707-709. 10.1182/blood-2002-01-0060. Green open access
file

Ancliff, PJ; Gale, RE; Watts, MJ; Liesner, R; Hann, IM; Strobel, S; Linch, DC; (2002) Paternal mosaicism proves the pathogenic nature of mutations in neutrophil elastase in severe congenital neutropenia. BLOOD , 100 (2) 707 - 709.

Arcaro, A; Khanzada, UK; Vanhaesebroeck, B; Tetley, TD; Waterfield, MD; Seckl, MJ; (2002) Two distinct phosphoinositide 3-kinases mediate polypeptide growth factor-stimulated PKB activation. EMBO JOURNAL , 21 (19) pp. 5097-5108. 10.1093/emboj/cdf512.

Arkenau, HT; Stichtenoth, DO; Frölich, JC; Manns, MP; Böker, KH; (2002) Elevated nitric oxide levels in patients with chronic liver disease and cirrhosis correlate with disease stage and parameters of hyperdynamic circulation. Z Gastroenterol , 40 (11) pp. 907-913. 10.1055/s-2002-35413.

Arkenau, HT; Widjaja, A; (2002) [A rare case of cholestasis and macrohematuria in a 52-year-old patient]. Med Klin (Munich) , 97 (8) pp. 480-483.

Attygalle, A; Al-Jehani, R; Diss, TC; Munson, P; Liu, HX; Du, MQ; Isaacson, PG; (2002) Neoplastic T cells in angioimmunoblastic T-cell lymphoma express CD10. BLOOD , 99 (2) pp. 627-633. 10.1182/blood.V99.2.627.

B

Baraldi, PG; Romagnoli, R; Guadix, AE; de las Infantas, MJP; Gallo, MA; Espinosa, A; Martinez, A; (2002) Design, synthesis, and biological activity of hybrid compounds between uramustine and DNA minor groove binder distamycin A. J MED CHEM , 45 (17) 3630 - 3638. 10.1021/jm011113b.

Baraldi, PG; Romagnoli, R; Pavani, MG; Nunez, MD; Bingham, JP; Hartley, JA; (2002) Benzoyl and cinnamoyl nitrogen mustard derivatives of benzoheterocyclic analogues of the tallimustine: Synthesis and antitumour activity. BIOORGAN MED CHEM , 10 (5) 1611 - 1618.

Barker, KT; Bevan, S; Wang, R; Lu, YJ; Flanagan, AM; Bridge, JA; Fisher, C; (2002) Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas. BRIT J CANCER , 87 (4) 446 - 448. 10.1038/sj.bjc.6600502.

Baselga, J; Rischin, D; Ranson, M; Calvert, H; Raymond, E; Kieback, DG; Kaye, SB; (2002) Phase I safety, pharmacokinetic, and pharmacodynamic trial of ZD1839, a selective oral epidermal growth factor receptor tyrosine kinase inhibitor, in patients with five selected solid tumor types. J CLIN ONCOL , 20 (21) 4292 - 4302. 10.1200/JCO.2002.03.100.

Bates, AW; (2002) Conjoined twins in the 16th century. TWIN RES , 5 (6) 521 - 528.

Bates, AW; (2002) Documentary evidence for conjoined twins in the sixteenth century. AM J MED GENET , 112 (4) 430 - 431. 10.1002/ajmg.10749.

Bates, AW; Baithun, SI; (2002) Secondary solid neoplasms of the prostate: a clinico-pathological series of 51 cases. VIRCHOWS ARCH , 440 (4) 392 - 396. 10.1007/s004280100505.

Bates, AW; Baithun, SI; (2002) Secondary tumours of the penis. J ROY SOC MED , 95 (3) 162 - 163.

Bates, AW; Baithun, SI; (2002) The significance of secondary neoplasms of the urinary and male genital tract. VIRCHOWS ARCH , 440 (6) 640 - 647. 10.1007/s00428-001-0549-x.

Bates, AW; Hall, CM; Morgan, H; Rosser, EM; Scheimberg, I; (2002) Lethal acrofacial dysostosis, pre- and post-axial defects of the hands, and bilateral renal agenesis. CLIN DYSMORPHOL , 11 (1) 63 - 66.

Batey, MA; Wright, JG; Azzabi, A; Newell, DR; Lind, MJ; Calvert, AH; Boddy, AV; (2002) Population pharmacokinetics of adjuvant cyclophosphamide, methotrexate and 5-fluorouracil (CMF). EUR J CANCER , 38 (8) 1081 - 1089.

Beauregard, DA; Pedley, RB; Hill, SA; Brindle, KM; (2002) Differential sensitivity of two adenocarcinoma xenografts to the anti-vascular drugs combretastatin A4 phosphate and 5,6-dimethylxanthenone-4-acetic acid, assessed using MRI and MRS. NMR BIOMED , 15 (2) 99 - 105. 10.1002/nbm.723.

Bellan, C; Lazzi, S; Zazzi, M; Lalinga, AV; Palummo, N; Galieni, P; Marafioti, T; (2002) Immunoglobulin gene rearrangement analysis in composite hodgkin disease and large B-cell lymphoma: evidence for receptor revision of immunoglobulin heavy chain variable region genes in Hodgkin-Reed-Sternberg cells? Diagn Mol Pathol , 11 (1) pp. 2-8.

Bernardi, R; Grisendi, S; Salomoni, P; Scaglioni, PP; Pandolfi, PP; (2002) The promyelocytic leukemia protein, PML, localizes to the nucleolus after DNA damage, interacts with Mdm2 and promotes p53 stability. In: BLOOD. (pp. 31A - 32A). AMER SOC HEMATOLOGY

Bernassola, F; Salomoni, P; Di Como, C; Pagano, N; Melino, G; Pandolfi, PP; (2002) PML enhances p73 transcriptional activity and biological functions by preventing its proteasome-dependent degradation. In: BLOOD. (pp. 177B - 177B). AMER SOC HEMATOLOGY

Bernstein, HG; Heinemann, A; Krell, D; Mawrin, C; Bielau, H; Danos, P; Diekmann, S; (2002) Further immunohistochemical evidence for impaired NO signaling in the hypothalamus of depressed patients. Ann N Y Acad Sci , 973 pp. 91-93.

Best, JL; Ganiatsas, S; Agarwal, S; Changou, A; Salomoni, P; Shirihai, O; Meluh, PB; (2002) SUMO-1 protease-1 regulates gene transcription through PML. MOL CELL , 10 (4) 843 - 855.

Biganzoli, L; Cufer, T; Bruning, P; Coleman, R; Duchateau, L; Calvert, AH; Gamucci, T; (2002) Doxorubicin and paclitaxel versus doxorubicin and cyclophosphamide as first-line chemotherapy in metastatic breast cancer: The European Organization for Research and Treatment of Cancer 10961 multicenter phase III trial. J CLIN ONCOL , 20 (14) 3114 - 3121. 10.1200/JCO.2002.11.005.

Bogunia-Kubik, K; Natarajan, P; Madrigal, JA; Cohen, SBA; (2002) The effect of cord blood sera on CD69 expression. IMMUNOL LETT , 84 (1) pp. 77-80.

Bomanji, JB; Syed, R; Brock, C; Jankowska, P; Dogan, A; Costa, DC; Ell, PJ; (2002) Challenging cases and diagnostic dilemmas: case 2. Pitfalls of positron emission tomography for assessing residual mediastinal mass after chemotherapy for Hodgkin's disease. J Clin Oncol , 20 (15) pp. 3347-3349. 10.1200/jco.2002.20.15.3347.

Boshoff, C; (2002) Kaposi's sarcoma biology. IUBMB LIFE , 53 (4-5) 259 - 261. 10.1080/15216540290099034.

Boshoff, C; (2002) Kaposi's sarcoma biology. IUBMB Life , 53 (4-5) pp. 259-261. 10.1080/15216540212645.

Boshoff, C; (2002) Targets for treatment: Lessons from aids-related malignancies. BRIT J CANCER , 86 S11 - S11.

Boshoff, C; Weiss, R; (2002) Aids-related malignancies. NAT REV CANCER , 2 (5) 373 - 382. 10.1038/nrc797.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; Chakraverty, RK; (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. Journal of Clinical Oncology , 20 (19) pp. 4022-4031. 10.1200/JCO.2002.11.088.

Branson, K; Chopra, R; Kottaridis, PD; McQuaker, G; Parker, A; Schey, S; Chakraverty, RK; (2002) Role of nonmyeloablative allogeneic stem-cell transplantation after failure of autologous transplantation in patients with lymphoproliferative malignancies. J CLIN ONCOL , 20 (19) 4022 - 4031. 10.1200/JCO.2002.11.088.

Brett, BT; Smith, SC; Bouvier, CV; Michaeli, D; Hochhauser, D; Davidson, BR; Kurzawinski, TR; (2002) Phase II study of anti-gastrin-17 antibodies, raised to G17DT, in advanced pancreatic cancer. J CLIN ONCOL , 20 (20) 4225 - 4231. 10.1200/JCO.2002.11.151.

Broceño, C; Wilkie, S; Mittnacht, S; (2002) RB activation defect in tumor cell lines. Proc Natl Acad Sci U S A , 99 (22) pp. 14200-14205. 10.1073/pnas.212519499.

Brock, CS; Lee, SM; (2002) Anti-angiogenic strategies and vascular targeting in the treatment of lung cancer. EUROPEAN RESPIRATORY JOURNAL , 19 (3) pp. 557-570. 10.1183/09031936.02.00293002.

Brooks, LA; Sullivan, A; O'Nions, J; Bell, A; Dunne, B; Tidy, JA; Evans, DJ; (2002) E7 proteins from oncogenic human papillomavirus types transactivate p73: role in cervical intraepithelial neoplasia. BRITISH JOURNAL OF CANCER , 86 (2) pp. 263-268. 10.1038/sj/bjc/6600033.

Brown, RSD; Edwards, J; Dogan, A; Payne, H; Harland, SJ; Bartlett, JMS; Masters, JRW; (2002) Amplification of the androgen receptor gene in bone metastases from hormone-refractory prostate cancer. J PATHOL , 198 (2) 237 - 244. 10.1002/path.1206.

Budhram-Mahadeo, V; Morris, P; Ndisang, D; Irshad, S; Lozano, G; Pedley, B; Latchman, DS; (2002) The Brn-3a POU family transcription factor stimulates p53 gene expression in human and mouse tumour cells. NEUROSCI LETT , 334 (1) 1 - 4.

Bunn, PA; Calvert, H; (2002) Pemetrexed, a novel multitargeted antifolate: Current development and future directions - Introduction. SEMIN ONCOL , 29 (2) 1 - 2. 10.1053/sonc.2002.30757.

C

Calvert, AH; Egorin, MJ; (2002) Carboplatin dosing formulae: gender bias and the use of creatinine-based methodologies. EUR J CANCER , 38 (1) 11 - 16.

Calvert, H; (2002) Folate status and the safety profile of antifolates. SEMINARS IN ONCOLOGY , 29 (2) 3 - 7. 10.1053/sonc.2002.30761.

Calvert, H; Bunn, PA; (2002) Future directions in the development of pemetrexed. SEMINARS IN ONCOLOGY , 29 (2) 54 - 61. 10.1053/sonc.2002.30761.

Calvert, H; Jodrell, DI; Cassidy, J; Harris, AL; (2002) Efficacy, safety, and cost of new anticancer drugs - Pessimistic conclusion was not justified. BRIT MED J , 325 (7375) 1302 - 1303.

Casey, JL; Napier, MP; King, DJ; Pedley, RB; Chaplin, LC; Weir, N; Skelton, L; (2002) Tumour targeting of humanised cross-linked divalent-Fab' antibody fragments: a clinical phase I/II study. Br J Cancer , 86 (9) pp. 1401-1410. 10.1038/sj.bjc.6600198.

Chakrabarti, S; Avivi, I; Mackinnon, S; Ward, K; Kottaridis, PD; Osman, H; Waldmann, H; (2002) Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality. BRIT J HAEMATOL , 119 (4) 1125 - 1132.

Chakrabarti, S; Mackinnon, S; Chopra, R; Kottaridis, PD; Peggs, K; O'Gorman, P; Chakraverty, R; (2002) High incidence of cytomegalovirus infection after nonmyeloablative stem cell transplantation: potential role of Campath-1H in delaying immune reconstitution. BLOOD , 99 (12) 4357 - 4363.

Chakraverty, R; Peggs, K; Chopra, R; Milligan, DW; Kottaridis, PD; Verfuerth, S; Geary, J; (2002) Limiting transplantation-related mortality following unrelated donor stem cell transplantation by using a nonmyeloablative conditioning regimen. BLOOD , 99 (3) 1071 - 1078.

Chantret, I; Dupré, T; Delenda, C; Bucher, S; Dancourt, J; Barnier, A; Charollais, A; (2002) Congenital disorders of glycosylation type Ig is defined by a deficiency in dolichyl-P-mannose:Man7GlcNAc2-PP-dolichyl mannosyltransferase. J Biol Chem , 277 (28) pp. 25815-25822. 10.1074/jbc.M203285200. Gold open access

Chatterjee, R; Kottaridis, PD; McGarrigle, HH; Linch, DC; (2002) Management of erectile dysfunction by combination therapy with testosterone and sildenafil in recipients of high-dose therapy for haematological malignancies. Bone Marrow Transplant , 29 (7) pp. 607-610. 10.1038/sj.bmt.1703421.

Chen, FE; Aubert, G; Travers, P; Dodi, IA; Madrigal, JA; (2002) HLA tetramers and anti-CMV immune responses: from epitope to immunotherapy. Cytotherapy , 4 (1) pp. 41-48.

Clark, FJ; Chakraverty, R; (2002) Role of dendritic cells in graft-versus-host disease. J HEMATOTH STEM CELL , 11 (4) 601 - 616.

Colledge, L; Bennett, CL; Reay, PA; Blackburn, CC; (2002) Rapid constitutive generation of a specific peptide-MHC class II complex from intact exogenous protein in immature murine dendritic cells. EUROPEAN JOURNAL OF IMMUNOLOGY , 32 (11) pp. 3246-3255. 10.1002/1521-4141(200211)32:11<3246::AID-IMMU3246>3.0.CO;2-B.

Colombari, R; Togni, R; Furlanetto, A; Quaglia, A; Dhillon, A; Demichelis, F; Spinoso, A; (2002) Royal free (RFH) scoring system for unifocal hepatocellular carcinoma (HCC) < 5 cm diameter: A valuable prognostic tool. J HEPATOL , 36 78 - 78.

Colombo, E; Marine, JC; Danovi, D; Falini, B; Pelicci, PG; (2002) Nucleophosmin regulates the stability and transcriptional activity of p53. NAT CELL BIOL , 4 (7) 529 - 533. 10.1038/ncb814.

Cooke, SP; Pedley, RB; Boden, R; Begent, RH; Chester, KA; (2002) In vivo tumor delivery of a recombinant single chain Fv::tumor necrosis factor-alpha fusion [correction of factor: a fusion] protein. Bioconjug Chem , 13 (1) pp. 7-15.

Corell, A; Cox, ST; Soteriou, B; Ramon, D; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*14011,*1402,*1403 and*1404 alleles. TISSUE ANTIGENS , 59 (1) pp. 66-69. 10.1034/j.1399-0039.2002.590116.x.

Corell, A; Little, AM; Marsh, SGE; Madrigal, JA; (2002) HLA matching in unrelated stem cell transplantation: what to type for? Inmunologia , 21: pp. 169-177.

Corrie, P; Mayer, A; Shaw, J; D'Ath, S; Blagden, S; Blesing, C; Price, P; (2002) Phase II study to evaluate combining gemcitabine with flutamide in advanced pancreatic cancer patients. BRITISH JOURNAL OF CANCER , 87 (7) pp. 716-719. 10.1038/sj.bjc.6600523.

Cox, ST; Ogilvie, H; Bohan, EM; Holman, R; Prentice, HG; Potter, M; Madrigal, JA; (2002) Sequence of two new HLA-Cw alleles: HLA-Cw*0313 and HLA-Cw*1208. Tissue Antigens , 59 (1) pp. 49-51.

Craddock, C; Hochhauser, D; (2002) Realising the potential of targeted therapies in oncology. LANCET , 360 (9331) 424 - 425.

D

Davidoff, AM; Nathwani, AC; Spurbeck, WW; Ng, CY; Zhou, J; Vanin, EF; (2002) rAAV-mediated long-term liver-generated expression of an angiogenesis inhibitor can restrict renal tumor growth in mice. Cancer Res , 62 (11) pp. 3077-3083.

Davies, H; Bignell, GR; Cox, C; Stephens, P; Edkins, S; Clegg, S; Teague, J; (2002) Mutations of the BRAF gene in human cancer. Nature , 417 (6892) pp. 949-954. 10.1038/nature00766.

Davis, BA; Porter, JB; (2002) Results of long term iron chelation treatment with deferoxamine. ADV EXP MED BIOL , 509 91 - 125.

De Silva, IU; McHugh, PJ; Clingen, PH; Hartley, JA; (2002) Defects in interstrand cross-link uncoupling do not account for the extreme sensitivity of ERCC1 and XPF cells to cisplatin. NUCLEIC ACIDS RES , 30 (17) 3848 - 3856. Gold open access

Delenda, C; Audit, M; Danos, O; (2002) Biosafety issues in lentivector production. Curr Top Microbiol Immunol , 261 pp. 123-141.

Dodi, IA; Van Rhee, F; Forde, HC; Roura-Mir, C; Jaraquemada, D; Goldman, JM; Madrigal, JA; (2002) CD4(+) bias in T cells cloned from a CML patient with active graft versus leukemia effect. Cytotherapy , 4 (4) pp. 353-363.

Donohoe, S; Quenby, S; Mackie, I; Panal, G; Farquharson, R; Malia, R; Kingdom, J; (2002) Fluctuations in levels of antiphospholipid antibodies and increased coagulation activation markers in normal and heparin-treated antiphospholipid syndrome pregnancies. LUPUS , 11 (1) 11 - 20. 10.1191/0961203302lu132oa.

Du, MQ; Diss, TC; Liu, HX; Ye, HT; Hamoudi, RA; Cabecadas, J; Dong, HY; (2002) KSHV- and EBV-associated germinotropic lymphoproliferative disorder. BLOOD , 100 (9) pp. 3415-3418. 10.1182/blood-2002-02-0487. Green open access
file

Duarte, R.F.; Chen, F.E.; Lowdell, M.W.; Potter, M.N.; Lamana, M.L.; Prentice, H.G.; Madrigal, J.A.; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. Gene Therapy , 9 (20) pp. 1359-1368. 10.1038/sj.gt.3301807.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: Implications for gene therapy. Gene Therapy , 9 (20) pp. 1359-1368. 10.1038/sj.gt.3301807.

Duarte, RF; Chen, FE; Lowdell, MW; Potter, MN; Lamana, ML; Prentice, HG; Madrigal, JA; (2002) Functional impairment of human T-lymphocytes following PHA-induced expansion and retroviral transduction: implications for gene therapy. GENE THER , 9 (20) 1359 - 1368. 10.1038/sj.gt.3301807.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; Marsh, SGE; (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. TISSUE ANTIGENS , 59 (6) pp. 522-524. 10.1034/j.1399-0039.2002.590610.x.

Dunne, C; Little, AM; Cox, ST; Masson, D; Crowley, J; Barnes, T; Marsh, SGE; (2002) Identification and nucleotide sequence of a new null allele, HLA B*3540N. Tissue Antigens , 59 (6) pp. 522-524.

E

Ellis, PE; Fong, LFWT; Rolfe, KJ; Crow, JC; Reid, WMN; Davidson, T; MacLean, AB; (2002) The role of p53 and Ki67 in Paget's disease of the vulva and the breast. GYNECOL ONCOL , 86 (2) 150 - 156. 10.1006/gyno.2002.6629.

Ellis, PE; Fong, LFWT; Rolfe, KJ; Crow, JC; Reid, WMN; Davidson, T; MacLean, AB; (2002) The role of vascular endothelial growth factor-A (VEGF-A) and platelet-derived endothelial cell growth factor/thymidine phosphorylase (PD-ECGF/TP) in Paget's disease of the vulva and breast. ANTICANCER RESEARCH , 22 (2A) 857 - 861.

Ezoe, S; Matsumura, I; Nakata, S; Gale, K; Ishihara, K; Minegishi, N; Machii, T; (2002) GATA-2/estrogen receptor chimera regulates cytokine-dependent growth of hematopoietic cells through accumulation of p21(WAF1) and p27(Kip1) proteins. BLOOD , 100 (10) pp. 3512-3520. 10.1182/blood-2002-04-1177.

F

Ferns, RB; Fletcher, H; Bradley, S; Mackinnon, S; Hunt, C; Tedder, RS; (2002) The prospective evaluation of a nested polymerase chain reaction assay for the early detection of Aspergillus infection in patients with leukaemia or undergoing allograft treatment. BRIT J HAEMATOL , 119 (3) 720 - 725.

Fielding, A; (2002) Cancer vaccines: unanswered questions. May 16, 2002, Phacilitate Spring Vaccine Forum, Cancer Vaccines, Paris, France. Expert Rev Vaccines , 1 (2) pp. 131-133. 10.1586/14760584.1.2.131.

Firat, H; Cochet, M; Rohrlich, PS; Garcia-Pons, F; Darche, S; Danos, O; Lemonnier, FA; (2002) Comparative analysis of the CD8(+) T cell repertoires of H-2 class I wild-type/HLA-A2.1 and H-2 class I knockout/HLA-A2.1 transgenic mice. Int Immunol , 14 (8) pp. 925-934.

Firat, H; Zennou, V; Garcia-Pons, F; Ginhoux, F; Cochet, M; Danos, O; Lemonnier, FA; (2002) Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapy. J Gene Med , 4 (1) pp. 38-45.

Flynn, AA; Green, AJ; Pedley, RB; Boxer, GM; Dearling, J; Watson, R; Boden, R; (2002) A model-based approach for the optimization of radioimmunotherapy through antibody design and radionuclide selection. Cancer , 94 (4 Suppl) pp. 1249-1257.

Flynn, AA; Pedley, RB; Green, AJ; Boxer, GM; Boden, R; Bhatia, J; Morris, R; (2002) Antibody and radionuclide characteristics and the enhancement of the effectiveness of radioimmunotherapy by selective dose delivery to radiosensitive areas of tumour. INT J RADIAT BIOL , 78 (5) 407 - 415. 10.1080/09553000110117818.

Forbes, LV; Gale, RE; Pizzey, A; Pouwels, K; Nathwani, A; Linch, DC; (2002) An activating mutation in the transmembrane domain of the granulocyte colony-stimulating factor receptor in patients with acute myeloid leukemia. ONCOGENE , 21 (39) 5981 - 5989. 10.1038/sj.onc.1205767.

Ford, HER; Mitchell, F; Cunningham, D; Farrugia, DC; Hill, ME; Rees, C; Calvert, AH; (2002) Patterns of elevation of plasma 2 '-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331. CLIN CANCER RES , 8 (1) 103 - 109.

Fordham-Skelton, AP; Chilley, P; Lumbreras, V; Reignoux, S; Fenton, TR; Dahm, CC; Pages, M; (2002) A novel higher plant protein tyrosine phosphatase interacts with SNF1-related protein kinases via a KIS (kinase interaction sequence) domain. Plant J , 29 (6) pp. 705-715.

Foroni, L; Hoffbrand, AV; (2002) Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY , 15 (1) pp. 71-90. 10.1053/beha.2002.0186.

Francis, RJ; Sharma, SK; Springer, C; Green, AJ; Hope-Stone, LD; Sena, L; Martin, J; (2002) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. British Journal of Cancer , 87 (6) pp. 600-607. 10.1038/sj.bjc.6600517.

Francis, RJ; Sharma, SK; Springer, C; Green, AJ; Hope-Stone, LD; Sena, L; Martin, J; (2002) A phase I trial of antibody directed enzyme prodrug therapy (ADEPT) in patients with advanced colorectal carcinoma or other CEA producing tumours. BRIT J CANCER , 87 (6) 600 - 607. 10.1038/sj.bjc.6600517.

Freeman, A; Treurnicht, K; Munson, P; Miller, K; Parkinson, MC; (2002) A comparison of basal cell markers used in the prostate. HISTOPATHOLOGY , 40 (5) pp. 492-494. 10.1046/j.1365-2559.2002.t01-6-01390.x.

G

Gale, RE; (2002) Basic sciences of the myeloproliferative diseases: Pathogenic mechanisms of ET and PV. INT J HEMATOL , 76 305 - 310.

Gameiro, P; Moreira, I; Yetgin, S; Papaioannou, M; Potter, MN; Prentice, HG; Hoffbrand, AV; (2002) Polymerase chain reaction (PCR)- and reverse transcription PCR-based minimal residual disease detection in long-term follow-up of childhood acute lymphoblastic leukaemia. BRITISH JOURNAL OF HAEMATOLOGY , 119 (3) pp. 685-696. 10.1046/j.1365-2141.2002.03911.x.

Gameiro, P; Mortuza, FY; Hoffbrand, AV; Foroni, L; (2002) Minimal residual disease monitoring in adult T-cell acute lymphoblastic leukemia: a molecular based approach using T-cell receptor gamma and delta gene rearrangements. HAEMATOLOGICA , 87 (11) pp. 1126-1134. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica , 87 (2) pp. 167-176. Gold open access

Ganeshaguru, K; Wickremasinghe, RG; Jones, DT; Gordon, M; Hart, SM; Virchis, AE; Prentice, HG; (2002) Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. HAEMATOLOGICA , 87 (2) 167 - 176. Gold open access

Gardiner, C; Cooper, PC; Makris, M; Mackie, IJ; Malia, RG; Machin, SJ; (2002) An evaluation of screening tests for defects in the protein C pathway: commercial kits lack sensitivity and specificity. BLOOD COAGUL FIBRIN , 13 (2) 155 - 163.

Gerrard, G; Ganeshaguru, K; Baker, R; Potter, M; Prentice, HG; Burgess, M; Herbert, L; (2002) Inhibition of P-gp activity in AML patients treated with zosuquidar trihydrochloride (LY335979): In vitro data from a phase 1 trial. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 67A-67A). AMER SOC HEMATOLOGY

Gill, J; Bourboulia, D; Wilkinson, J; Hayes, P; Cope, A; Marcelin, AG; Calvez, V; (2002) Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma--associated herpesvirus infection in patients with and without Kaposi sarcoma. J Acquir Immune Defic Syndr , 31 (4) pp. 384-390.

Gill, J; Bourboulia, D; Wilkinson, J; Hayes, P; Cope, A; Marcelin, AG; Calvez, V; (2002) Prospective study of the effects of antiretroviral therapy on Kaposi sarcoma-associated herpesvirus infection in patients with and without Kaposi sarcoma. JAIDS-J ACQ IMM DEF , 31 (4) 384 - 390.

Goetz, P; Lafuente, J; Revesz, T; Galloway, M; Dogan, A; Kitchen, N; (2002) Primary low-grade B-cell lymphoma of mucosa-associated lymphoid tissue of the dura mimicking the presentation of an acute subdural hematoma - Case report and review of the literature. J NEUROSURG , 96 (3) 611 - 614.

Going, JJ; Keith, WN; Neilson, L; Stoeber, K; Stuart, RC; Williams, GH; (2002) Aberrant expression of minichromosome maintenance proteins 2 and 5, and Ki-67 in dysplastic squamous oesophageal epithelium and Barrett's mucosa. GUT , 50 (3) 373 - 377. Green open access
file

Gonzalez, M; Quezada, SA; Blazar, BR; Panoskaltsis-Mortari, A; Rudensky, AY; Noelle, RJ; (2002) The balance between donor T cell anergy and suppression versus lethal graft-versus-host disease is determined by host conditioning. J IMMUNOL , 169 (10) 5581 - 5589.

Gordon, FH; Hamilton, MI; Donoghue, S; Greenlees, C; Palmer, T; Rowley-Jones, D; Dhillon, AP; (2002) A pilot study of treatment of active ulcerative colitis with natalizumab, a humanized monoclonal antibody to alpha-4 integrin. ALIMENT PHARM THER , 16 (4) 699 - 705.

Gore, M; Oza, A; Rustin, G; Malfetano, J; Calvert, H; Clarke-Pearson, D; Carmichael, J; (2002) A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer. EUR J CANCER , 38 (1) 57 - 63.

Gower, NH; Rudd, RM; James, LE; Gregory, W; Eisen, T; Lee, SM; Harper, PG; (2002) Gemcitabine/carboplatin (GC) versus mitomycin/ifosfamide/cisplatin (MIP): A randomised comparison in patients with advanced non-small cell lung cancer (NSCLC). BRITISH JOURNAL OF CANCER , 86 S1-S1.

Grasso, A; Quaglia, A; Montalto, P; Dhillon, AP; Patch, D; Davidson, B; Rolles, K; (2002) HCC and liver transplantation (LT): Risk factors for recurrence. In: J HEPATOL. (pp. 80 - 80). ELSEVIER SCIENCE BV

Grimaldi, KA; McGurk, CJ; McHugh, PJ; Hartley, JA; (2002) PCR-based methods for detecting DNA damage and its repair at the sub-gene and single nucleotide levels in cells. MOL BIOTECHNOL , 20 (2) 181 - 196.

Grimwade, D; Outram, SV; Flora, R; Ings, SJ; Pizzey, AR; Morilla, R; Craddock, CF; (2002) The T-Lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. CANCER RES , 62 (16) 4730 - 4735.

H

Hale, G; Slavin, S; Goldman, JM; Mackinnon, S; Giralt, S; Waldmann, H; (2002) Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nomnyeloablative conditioning? BONE MARROW TRANSPL , 30 (12) 797 - 804. 10.1038/sj.bmt.1703733.

Hamidi, AEL; Liu, HX; Zhang, Y; Hamoudi, R; Kocjan, G; Du, MQ; (2002) Archival cervical smears: a versatile resource for molecular investigations. CYTOPATHOLOGY , 13 (5) 291 - 299.

Hamoudi, RA; Diss, TC; Oksenhendler, E; Pan, LX; Carbone, A; Boshoff, C; Isaacson, P; (2002) Different cellular origin between primary effusion lymphoma with and without EBV infection. In: BLOOD. (pp. 564A - 564A). AMER SOC HEMATOLOGY

Haralambieva, E; Jones, M; Roncador, GM; Cerroni, L; Lamant, L; Ott, G; Rosenwald, A; (2002) Tyrosine phosphorylation in human lymphomas. Histochem J , 34 (11-12) pp. 545-552.

Harbord, M; Novelli, M; Canas, B; Power, D; Davis, C; Godovac-Zimmermann, J; Roes, J; (2002) Ym1 is a neutrophil granule protein that crystallizes in p47(phox)-deficient mice. J BIOL CHEM , 277 (7) 5468 - 5475. 10.1074/jbc.M110635200. Gold open access

Harris, RA; Yang, A; Stein, RC; Lucy, K; Brusten, L; Herath, A; Parekh, R; (2002) Cluster analysis of an extensive human breast cancer cell line protein expression map database. PROTEOMICS , 2 (2) pp. 212-223. 10.1002/1615-9861(200202)2:2<212::AID-PROT212>3.0.CO;2-H.

Harrison, CJ; Mazzullo, H; Ross, FM; Cheung, KL; Gerrard, G; Harewood, L; Mehta, A; (2002) Translocations of 14q32 and deletions of 13q14 are common chromosomal abnormalities in systemic amyloidosis. BRIT J HAEMATOL , 117 (2) 427 - 435.

Harrison, CN; Donohoe, S; Carr, P; Dave, M; Mackie, I; Machin, SJ; (2002) Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis. THROMB HAEMOSTASIS , 87 (5) 802 - 807.

Harrison, P; Robinson, M; Liesner, R; Khair, K; Cohen, H; Mackie, I; Machin, S; (2002) The PFA-100((R)): a potential rapid screening tool for the assessment of platelet dysfunction. CLIN LAB HAEMATOL , 24 (4) 225 - 232.

Hart, SM; Foroni, L; (2002) Core binding factor genes and human leukemia. HAEMATOLOGICA , 87 (12) pp. 1307-1323. Gold open access

Hercus, B; Saeed, S; Revell, PA; (2002) Expression profile of T cell associated molecules in the interfacial tissue of aseptically loosened prosthetic joints. J Mater Sci Mater Med , 13 (12) pp. 1153-1156.

Herrero, J; Dopazo, J; (2002) Combining hierarchical clustering and self-organizing maps for exploratory analysis of gene expression patterns. JOURNAL OF PROTEOME RESEARCH , 1 (5) pp. 467-470. 10.1021/pr025521v.

Herrero-Martinez, E; Sabin, CA; Evans, JG; Griffioen, A; Lee, CA; Emery, VC; (2002) The prognostic value of a single hepatitis C virus RNA load measurement taken early after human immunodeficiency virus seroconversion. J INFECT DIS , 186 (4) 470 - 476.

Heyworth, C; Pearson, S; May, G; Enver, T; (2002) Transcription factor-mediated lineage switching reveals plasticity in primary committed progenitor cells. EMBO JOURNAL , 21 (14) pp. 3770-3781. 10.1093/emboj/cdf368.

Howard, J; Hoffbrand, AV; Prentice, HG; Mehta, A; (2002) Mycophenolate mofetil for the treatment of refractory auto-immune haemolytic anaemia and auto-immune thrombocytopenia purpura. BRITISH JOURNAL OF HAEMATOLOGY , 117 (3) pp. 712-715. 10.1046/j.1365-2141.2002.03430.x.

Howard, TT; Lingerfelt, BM; Purnell, BL; Scott, AE; Price, CA; Townes, HM; McNulty, L; (2002) Novel furano analogues of duocarmycin C1 and C2: Design, synthesis, and biological evaluation of seco-iso-cyclopropylfurano[2,3-e]indoline (seco-iso-CFI) and seco-cyclopropyltetrahydrofurano[2,3-f]quinoline (seco-CFQ) analogues. BIOORGAN MED CHEM , 10 (9) 2941 - 2952.

Hughes, A; Calvert, P; Azzabi, A; Plummer, R; Johnson, R; Rusthoven, J; Griffin, M; (2002) Phase I clinical and pharmacokinetic study of pemetrexed and carboplatin in patients with malignant pleural mesothelioma. J CLIN ONCOL , 20 (16) 3533 - 3544. 10.1200/JCO.2002.10.073.

Hughes, SE; (2002) Cardiac stem cells. The Journal of Pathology (197) pp. 468-478.

Hughes, SE; (2002) Heart muscle disease. Medicine (30) pp. 89-91.

Hughes, SE; (2002) Expression of the Fibrogrowth Factor (FgF and the Fibroblast Growth Factor Receptor (FGFR)Multigene Families in Normal and Atherosclerotic Human Arteries. In: Pedro, C, (ed.) Fibroblast Growth Factor in the Cardiovascular System. (pp. 117-131). I Holzapfel: Munich.

Huntly, BJP; Bench, AJ; Delabesse, E; Reid, AG; Li, J; Scott, MA; Campbell, L; (2002) Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instability. In: BLOOD. (pp. 4547 - 4553). AMER SOC HEMATOLOGY

I

Imrie, KR; Linch, DC; Czuczman, MS; (2002) Debate on the conservative and aggressive treatment options for the optimal management of indolent non-Hodgkin's lymphoma. ANTI-CANCER DRUGS , 13 S19 - S24.

J

James, CT; Ohazama, A; Tucker, AS; Sharpe, PT; (2002) Tooth development is independent of a Hox patterning programme. Dev Dyn , 225 (3) pp. 332-335. 10.1002/dvdy.10168.

James, R.D.; Maughan, T.S.; Kerr, D.J.; Ledermann, J.A.; McArdle, C.; Seymour, M.T.; Cohen, D.; (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. The Lancet , 359 (9317) pp. 1555-1563. 10.1016/S0140-6736(02)08514-8.

Janinis, J; McTiernan, A; Driver, D; Mitchell, C; Cassoni, AM; Pringle, J; Kilby, A; (2002) A pilot study of short-course intensive multiagent chemotherapy in metastatic and axial skeletal osteosarcoma. ANN ONCOL , 13 (12) 1935 - 1944. 10.1093/annonc/mdf338.

Jenner, RG; Boshoff, C; (2002) The molecular pathology of Kaposi's sarcoma-associated herpesvirus. BBA-REV CANCER , 1602 (1) 1 - 22.

Jennings, I; Greaves, M; Mackie, IJ; Kitchen, S; Woods, TAL; Preston, FE; UK Natl External Quality Assessmen, ; (2002) Lupus anticoagulant testing: improvements in performance in a UKNEQAS proficiency testing exercise after dissemination of national guidelines on laboratory methods. BRIT J HAEMATOL , 119 (2) 364 - 369.

Jones, B; Aird, E; Colyer, H; Dobbs, J; Harris, R; Hoskin, P; McKenzie, A; (2002) United Kingdom Radiation Oncology 1 conference (UKRO 1): Accuracy and uncertainty in radiotherapy. BRITISH JOURNAL OF RADIOLOGY , 75 (892) pp. 297-306.

Joshi, CV; Enver, T; (2002) Plasticity revisited. CURRENT OPINION IN CELL BIOLOGY , 14 (6) pp. 749-755. 10.1016/A0955-0674(02)00392-7.

K

Kenny, PA; Enver, T; Ashworth, A; (2002) Retroviral vectors for establishing tetracycline-regulated gene expression in an otherwise recalcitrant cell line. BMC MOL BIOL , 3 , Article 13. 10.1186/1471-2199-3-13. Green open access
file

Khan, AW; Dhillon, AP; Hutchins, R; Abraham, A; Shah, SR; Snooks, S; Davidson, BR; (2002) Prognostic significance of intratumoural microvessel density (IMD) in resected pancreatic and ampullary cancers to standard histopathological variables and survival. EUROPEAN JOURNAL OF SURGICAL ONCOLOGY , 28 (6) 637 - 644. 10.1053/ejso.2002.1307.

Kiakos, K; Howard, TT; Lee, M; Hartley, JA; McHugh, PJ; (2002) Saccharomyces cerevisiae RAD5 influences the excision repair of DNA minor groove adducts. J BIOL CHEM , 277 (46) 44576 - 44581. 10.1074/jbc.M208169200. Gold open access

Kichler, A; Chillon, M; Leborgne, C; Danos, O; Frisch, B; (2002) Intranasal gene delivery with a polyethylenimine-PEG conjugate. J Control Release , 81 (3) pp. 379-388.

Kirkham, LA; Bateman, AR; Melcher, AA; Vile, RG; Fielding, AK; (2002) Lack of specificity of cell-surface protease targeting of a cytotoxic hyperfusogenic gibbon ape leukaemia virus envelope glycoprotein. JOURNAL OF GENE MEDICINE , 4 (6) pp. 592-600. 10.1002/jgm.306.

Kitajima, K; Masuhara, M; Era, T; Enver, T; Nakano, T; (2002) GATA-2 and GATA-2/ER display opposing activities in the development and differentiation of blood progenitors. EMBO JOURNAL , 21 (12) pp. 3060-3069. 10.1093/emboj/cdf301.

Koch, SSC; Thoresen, LH; Tikhe, JG; Maegley, KA; Almassy, RJ; Li, JK; Yu, XH; (2002) Novel tricyclic poly(ADP-ribose) polymerase-1 inhibitors with potent anticancer chemopotentiating activity: Design, synthesis, and X-ray cocrystal structure. J MED CHEM , 45 (23) 4961 - 4974. 10.1021/jm02059n.

Koh, MBC; Prentice, HG; Corbo, M; Morgan, M; Cotter, FE; Lowdell, MW; (2002) Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftment. BRIT J HAEMATOL , 118 (1) 108 - 116.

Kottaridis, PD; Gale, RE; Langabeer, SE; Frew, ME; Bowen, DT; Linch, DC; (2002) Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibitors. BLOOD , 100 (7) 2393 - 2398. 10.1182/blood-2002-02-0420.

Kottaridis, PD; Peggs, K; Schmitz, N; Dreger, P; Boogaerts, MA; Ferrant, A; Demuynck, HM; (2002) Survival and freedom from progression in autotransplant lymphoma patients is independent of stem cell source: Further follow-up from the original randomised study to assess engraftment. LEUKEMIA LYMPHOMA , 43 (3) 531 - 536. 10.1080/10428190290012010.

Kralovicova, J; Marsh, SGE; Waller, MJ; Hammarstrom, L; Vorechovsky, I; (2002) The HLA-DRA*0102 allele: Correct nucleotide sequence and associated HLA haplotypes. TISSUE ANTIGENS , 60 (3) pp. 266-267. 10.1034/j.1399-0039.2002.600310.x.

Kularatne, BY; Lorigan, P; Browne, S; Suvarna, SK; Smith, NO; Lawry, J; (2002) Monitoring tumour cells in the peripheral blood of small cell lung cancer patients. CYTOMETRY , 50 (3) 160 - 167. 10.1002/cyto.10071.

L

Lagging, LM; Garcia, CE; Westin, J; Wejstal, R; Norkrans, G; Dhillon, AP; Lindh, M; (2002) Comparison of serum hepatitis C virus RNA and core antigen concentrations and determination of whether levels are associated with liver histology or affected by specimen storage time. J CLIN MICROBIOL , 40 (11) 4224 - 4229. 10.1128/JCM.40.11.4224-4229.2002.

Lagging, LM; Westin, J; Svensson, E; Aires, N; Dhillon, AP; Lindh, M; Wejstal, R; (2002) Progression of fibrosis in untreated patients with hepatitis C virus infection. LIVER , 22 (2) 136 - 144.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia. Leukemia , 16 (3) pp. 393-399. 10.1038/sj.leu.2402392.

Langabeer, SE; Gale, RE; Harvey, RC; Cook, RW; Mackinnon, S; Linch, DC; (2002) Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transript levels in patients with chronic myeloid leukaemia. LEUKEMIA , 16 (3) 393 - 399. 10.1038/sj/leu/2402392.

Langabeer, SE; Gale, RE; Rollinson, SJ; Morgan, GJ; Linch, DC; (2002) Mutations of the AML1 gene in acute myeloid leukemia of FAB types M0 and M7. GENE CHROMOSOME CANC , 34 (1) 24 - 32. 10.1002/gcc.10031.

Lee, Y.C.; Boehm, M.K.; Chester, K.A.; Begent, R.H.J.; Perkins, S.J.; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. Journal of Molecular Biology , 320 (1) pp. 107-127. 10.1016/S0022-2836(02)00403-5.

Lee, YC; Boehm, MK; Chester, KA; Begent, RHJ; Perkins, SJ; (2002) Reversible dimer formation and stability of the anti-tumour single-chain Fv antibody MFE-23 by neutron scattering, analytical ultracentrifugation, and NMR and FT-IR spectroscopy. J MOL BIOL , 320 (1) 107 - 127. 10.1016/S0022-2836(02)00403-5.

Leonard, P; Seymour, MT; James, R; Hochhauser, D; Ledermann, JA; (2002) Phase II study of irinotecan with bolus and high dose infusional 5-FU and folinic acid (modified de Gramont) for first or second line treatment of advanced or metastatic colorectal cancer. Br J Cancer , 87 (11) pp. 1216-1220. 10.1038/sj.bjc.6600641.

Liu, HX; Huang, XB; Zhang, Y; Ye, HT; El Hamidi, A; Kocjan, G; Dogan, A; (2002) Archival fixed histologic and cytologic specimens including stained and unstained materials are amenable to RT-PCR. DIAGN MOL PATHOL , 11 (4) 222 - 227.

Liu, HX; Ye, HT; Ruskone-Fourmestraux, A; De Jong, D; Pileri, S; Thiede, C; Lavergne, A; (2002) T(11;18) is a marker for all stage gastric MALT lymphomas that will not respond to H-pylori eradication. GASTROENTEROLOGY , 122 (5) pp. 1286-1294. 10.1053/gast.2002.33047.

Liu, Y; Dodds, P; Emilion, G; Mungall, AJ; Dunham, I; Beck, S; Wells, RS; (2002) The human homologue of unc-93 maps to chromosome 6q27 - characterisation and analysis in sporadic epithelial ovarian cancer. BMC Genetics , 3 , Article 20. 10.1186/1471-2156-3-20. Green open access
file

Liu, Y; Emilion, G; Mungall, AJ; Dunham, I; Beck, S; Le Meuth-Metzinger, VG; Shelling, AN; (2002) Physical and transcript map of the region between D6S264 and D6S149 on chromosome 6q27, the minimal region of allele loss in sporadic epithelial ovarian cancer. ONCOGENE , 21 (3) 387 - 399.

Liu, ZD; Kayyali, R; Hider, RC; Porter, JB; Theobald, AE; (2002) Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: Structure-activity investigation of metalloenzyme inhibition by iron chelators. J MED CHEM , 45 (3) 631 - 639. 10.1021/jm010817i.

Lowdell, MW; Craston, R; Samuel, D; Wood, ME; O'Neill, E; Saha, V; Prentice, HG; (2002) Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cells. BRIT J HAEMATOL , 117 (4) 821 - 827.

M

Mackie, IJ; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GDO; Martin, J; (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. THROMB HAEMOSTASIS , 87 (6) 997 - 1005.

Mackie, IJ; Lawrie, AS; Purdy, G; Williams, T; Machin, SJ; (2002) DX-88, a novel Kunitz-type inhibitor of human plasma kallikrein with potential therapeutic use. In: BLOOD. (pp. 88B - 89B). AMER SOC HEMATOLOGY

Mackie, J; Lawrie, AS; Kitchen, S; Gaffney, PJ; Howarth, D; Lowe, GD; Martin, J; (2002) A performance evaluation of commercial fibrinogen reference preparations and assays for Clauss and PT-derived fibrinogen. Thromb Haemost , 87 (6) pp. 997-1005.

Manderson, EN; Presneau, N; Provencher, D; Mes-Masson, AM; Tonin, PN; (2002) Comparative analysis of loss of heterozygosity of specific chromosome 3, 13, 17, and X loci and TP53 mutations in human epithelial ovarian cancer. MOL CARCINOGEN , 34 (2) 78 - 90. 10.1002/mc.10051.

Marsh, SG; (2002) Nomenclature for factors of the HLA System, update September 2001. Eur J Immunogenet , 29 (1) 79-.

Marsh, SG; (2002) Nomenclature for factors of the HLA system, update April 2002. Eur J Immunogenet , 29 (5) pp. 457-458.

Marsh, SG; (2002) Nomenclature for factors of the HLA system, update February 2002. Eur J Immunogenet , 29 (3) 277-.

Marsh, SG; (2002) Nomenclature for factors of the HLA system, update January 2002. Eur J Immunogenet , 29 (3) 275-.

Marsh, SG; (2002) Nomenclature for factors of the HLA system, update June 2002. Eur J Immunogenet , 29 (5) 461-.

Marsh, SG; (2002) Nomenclature for factors of the HLA system, update March 2002. Eur J Immunogenet , 29 (3) pp. 279-280.

Marsh, SG; (2002) Nomenclature for factors of the HLA system, update May 2002. Eur J Immunogenet , 29 (5) 459-.

Marsh, SG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2002) Nomenclature for factors of the HLA system, 2002. Tissue Antigens , 60 (5) pp. 407-464.

Marsh, SG; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2002) Nomenclature for factors of the HLA system, 2002. Hum Immunol , 63 (12) pp. 1213-1268.

Marsh, SG; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update December 2001. Tissue Antigens , 59 (2) pp. 172-173.

Marsh, SG; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update November 2001. Tissue Antigens , 59 (2) pp. 170-171.

Marsh, SG; WHO Nomemclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update October 2001. Tissue Antigens , 59 (2) pp. 168-169.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update April 2002. Hum Immunol , 63 (9) pp. 795-796.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update August 2001. Tissue Antigens , 59 (1) pp. 73-74.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Hum Immunol , 63 (6) 514-.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Hum Immunol , 63 (6) pp. 515-516.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update September 2001. Tissue Antigens , 59 (1) pp. 75-76.

Marsh, SG; WHO Nomenclature Committee for Factors of the HLA System, ; (2002) Nomenclature for factors of the HLA system, updated May 2002. Hum Immunol , 63 (10) 966-.

Marsh, SG; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update February 2002. Tissue Antigens , 59 (3) pp. 237-238.

Marsh, SG; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update January 2002. Tissue Antigens , 59 (3) pp. 235-236.

Marsh, SG; Who Nomenclature Committee for Factor of the HLA System, ; (2002) Nomenclature for factors of the HLA system, update March 2002. Tissue Antigens , 59 (3) pp. 239-240.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update December 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 117. 10.1046/j.1365-2370.2002.00317.x.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update November 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 115. 10.1046/j.1365-2370.2002.00316.x.

Marsh, SGE; (2002) Nomenclature for factors of the HLA system, update October 2001. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (2) p. 113. 10.1046/j.1365-2370.2002.00315.x.

Marsh, SGE; Albert, ED; Bodmer, WF; Bontrop, RE; Dupont, B; Erlich, HA; Geraghty, DE; (2002) Nomenclature for factors of the HLA system, 2002. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (6) pp. 463-516. 10.1046/j.1365-2370.2002.00359.x.

Maughan, TS; James, RD; Kerr, DJ; Ledermann, JA; McArdle, C; Seymour, MT; Cohen, D; (2002) Comparison of survival, palliation, and quality of life with three chemotherapy regimens in metastatic colorectal cancer: a multicentre randomised trial. LANCET , 359 (9317) 1555 - 1563.

Mayer, A; Spencer, DIR; Tolner, B; Purdy, D; Begent, RHJ; Chester, K; (2002) A recombinant fusion protein with potentially reduced immunogenicity for ADEPT. British Journal of Cancer , 86 S117-S117.

Mayer, A; Spencer, DIR; Tolner, B; Purdy, D; Begent, RHJ; Chester, K; (2002) A recombinant fusion protein with potentially reduced immunogenicity for ADEPT. BRIT J CANCER , 86 S117 - S117.

McIlhatton, BP; Keating, C; Curran, MD; McMullin, MF; Barr, JG; Madrigal, JA; Middleton, D; (2002) Identification of medically important pathogenic fungi by reference strand-mediated conformational analysis (RSCA). J MED MICROBIOL , 51 (6) pp. 468-478.

Mezzina, M; Danos, O; (2002) Five years of vector service for gene therapy. Trends Genet , 18 (3) pp. 118-119.

Migliorini, D; Danovi, D; Colombo, E; Carbone, R; Pelicci, PG; Marine, JC; (2002) Hdmx recruitment into the nucleus by Hdm2 is essential for its ability to regulate p53 stability and transactivation. J BIOL CHEM , 277 (9) 7318 - 7323. 10.1074/jbc.M108795200. Gold open access

Migliorini, D; Denchi, EL; Danovi, D; Jochemsen, A; Capillo, M; Gobbi, A; Helin, K; (2002) Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development. MOL CELL BIOL , 22 (15) 5527 - 5538. 10.1128/MCB.22.15.5527-5538.2002.

Monastiri, K; Ben Ahmed, S; Presneau, N; Bignon, JY; Chouchane, L; (2002) [Rapid detection of BRCA-1 germline mutations by the protein truncation test in Tunisian families]. Tunis Med , 80 (9) pp. 515-518.

N

Nacheva, EP; Reid, AG; Tarpey, PS; Grace, CD; (2002) Quantification of locus copy number in chronic myeloid leukaemia using multiplex amplifiable probe hybridisation (MAPH). In: BLOOD. (pp. 325B - 325B). AMER SOC HEMATOLOGY

Nakahara, T; Yaguchi, H; Yoshida, M; Miyakoshi, J; (2002) Effects of exposure of CHO-K1 cells to a 10-T static magnetic field. Radiology , 224 (3) pp. 817-822. 10.1148/radiol.2243011300.

Nehls, O; Klump, B; Arkenau, HT; Hass, HG; Greschniok, A; Gregor, M; Porschen, R; (2002) Oxaliplatin, fluorouracil and leucovorin for advanced biliary system adenocarcinomas: a prospective phase II trial. Br J Cancer , 87 (7) pp. 702-704. 10.1038/sj.bjc.6600543.

Newton, R; Ziegler, J; Ateenyi-Agaba, C; Bousarghin, L; Casabonne, D; Beral, V; Mbidde, E; (2002) The epidemiology of conjunctival squamous cell carcinoma in Uganda. BRIT J CANCER , 87 (3) 301 - 308. 10.1038/sj.bjc.6600451.

Nicholson, PW; Harland, SJ; (2002) Survival prospects after screen-detection of prostate cancer. BJU INT , 90 (7) 686 - 693. 10.1046/j.1464-4096.2002.03005.x.

Nikitenko, LL; Smith, DM; Hague, S; Wilson, CR; Bicknell, R; Rees, MCP; (2002) Adrenomedullin and the microvasculature. TRENDS PHARMACOL SCI , 23 (3) 101 - 103.

Nimmo, R; Woollard, A; (2002) Widespread organisation of C-elegans genes into operons: fact or function? BIOESSAYS , 24 (11) pp. 983-987. 10.1002/bies.10181.

Niyikiza, C; Baker, SD; Seitz, DE; Walling, JM; Nelson, K; Rusthoven, JJ; Stabler, SP; (2002) Homocysteine and methylmalonic acid: Markers to predict and avoid toxicity from pemetrexed therapy. MOL CANCER THER , 1 (7) 545 - 552.

Niyikiza, C; Hanauske, AR; Rusthoven, JJ; Calvert, AH; Allen, R; Paoletti, P; Bunn, PA; (2002) Pemetrexed safety and dosing strategy. SEMIN ONCOL , 29 (6) 24 - 29. 10.1053/sonc.2002.37465.

Novik, KL; Nimmrich, I; Genc, B; Maier, S; Piepenbrock, C; Olek, A; Beck, S; (2002) Epigenomics: genome-wide study of methylation phenomena. Curr Issues Mol Biol , 4 (4) pp. 111-128. Gold open access

O

O'Hare, CC; Mack, D; Tandon, M; Sharma, SK; Lown, JW; Kopka, ML; Dickerson, RE; (2002) DNA sequence recognition in the minor groove by crosslinked polyamides: The effect of N-terminal head group and linker length on binding affinity and specificity. P NATL ACAD SCI USA , 99 (1) 72 - 77.

Oakley, TJ; Goodwin, A; Chakraverty, RK; Hickson, ID; (2002) Inactivation of homologous recombination suppresses defects in topoisomerase III-deficient mutants. DNA Repair (Amst) , 1 (6) pp. 463-482.

Ohkura, N; Yaguchi, H; Tsukada, T; Yamaguchi, K; (2002) The EWS/NOR1 fusion gene product gains a novel activity affecting pre-mRNA splicing. J Biol Chem , 277 (1) pp. 535-543. 10.1074/jbc.M109018200. Gold open access

Okkenhaug, K; Bilancio, A; Farjot, G; Priddle, H; Sancho, S; Peskett, E; Pearce, W; (2002) Impaired B and T cell antigen receptor signaling in p110 delta PI 3-kinase mutant mice. SCIENCE , 297 (5583) pp. 1031-1034.

Oksenhendler, E; Boulanger, E; Galicier, L; Du, MQ; Dupin, N; Diss, TC; Hamoudi, R; (2002) High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. BLOOD , 99 (7) 2331 - 2336.

P

Panaretou, B; Siligardi, G; Meyer, P; Maloney, A; Sullivan, JK; Singh, S; Millson, SH; (2002) Activation of the ATPase activity of Hsp90 by the stress-regulated cochaperone Aha1. MOLECULAR CELL , 10 (6) pp. 1307-1318. 10.1016/S1097-2765(02)00785-2.

Parmar, MKB; Adams, M; Balestrino, M; Bertelsen, K; Bonazzi, C; Calvert, H; Colombo, N; (2002) Paclitaxel plus carboplatin versus standard chemotherapy with either single-agent carboplatin or cyclophosphamide, doxorubicin, and cisplatin in women with ovarian cancer: the ICON3 randomised trial. LANCET , 360 (9332) 505 - 515.

Parsons, MJ; Pollard, SM; Saúde, L; Feldman, B; Coutinho, P; Hirst, EM; Stemple, DL; (2002) Zebrafish mutants identify an essential role for laminins in notochord formation. Development , 129 (13) pp. 3137-3146.

Patel, K; Stein, R; Benvenuti, S; Zvelebil, MJ; (2002) Combinatorial use of mRNA and two-dimensional electrophoresis expression data to choose relevant features for mass spectrometric identification. PROTEOMICS , 2 (10) pp. 1464-1473. 10.1002/1615-9861(200210)2:10<1464::AID-PROT1464>3.0.CO;2-9.

Patel, Y; Moraes, YC; Latchman, D; Coffin, R; de Belleroche, J; (2002) Neuroprotective effects of copper/zinc-dependent superoxide dismutase against a wide variety of death-inducing stimuli and proapoptotic effect of familial amyotrophic lateral sclerosis mutations. MOL BRAIN RES , 109 (1-2) 189 - 197.

Paul, MJ; Summers, Y; Calvert, AH; Rustin, G; Brampton, MH; Thatcher, N; Middleton, MR; (2002) Effect of temozolomide on central nervous system relapse in patients with advanced melanoma. MELANOMA RES , 12 (2) 175 - 178.

Payne, EM; Gerrard, G; Ganeshaguru, K; McCullough, H; Ethell, M; Potter, M; Prentice, HG; (2002) A phase 1 study of the P-glycoprotein inhibitor zosuquidar trihydrochloride (LY335979) in combination with daunorubicin and cytarabine in adult acute myeloid leukemia. In: (Proceedings) 44th Annual Meeting of the American-Society-of-Hematology. (pp. 557A-557A). AMER SOC HEMATOLOGY

Pedley, RB; El-Emir, E; Flynn, AA; Boxer, GM; Dearling, J; Raleigh, JA; Hill, SA; (2002) Synergy between vascular targeting agents and antibody-directed therapy. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS , 54 (5) 1524 - 1531.

Peggs, K; Verfuerth, S; Pizzey, A; Ainsworth, J; Moss, P; Mackinnon, S; (2002) Characterization of human cytomegalovirus peptide-specific CD8(+) T-cell repertoire diversity following in vitro restimulation by antigen-pulsed dendritic cells. BLOOD , 99 (1) 213 - 223.

Peggs, KS; Mackinnon, S; (2002) Adoptive cellular therapy: a therapeutic reality? Hematology , 7 (3) pp. 127-136. 10.1080/1024533021000013915.

Peggs, KS; Mackinnon, S; (2002) Clinical trials with CMV-specific T cells. CYTOTHERAPY , 4 (1) 21 - 28.

Peggs, KS; Mackinnon, S; Yong, K; (2002) Reduced intensity conditioning and allogeneic stem-cell transplantation: Determining its role in multiple myeloma. J CLIN ONCOL , 20 (20) 4268 - 4268.

Peggs, KS; Morris, EC; Kottaridis, PD; Geary, J; Goldstone, AH; Linch, DC; Mackinnon, S; (2002) Outcome of major ABO-incompatible nonmyeloablative hematopoietic stem cell transplantation may be influenced by conditioning regimen. BLOOD , 99 (12) 4642 - 4643.

Peggs, KS; Paneesha, S; Kottaridis, PD; Chakraverty, RK; Tobias, G; Reilly, M; Mahendra, P; (2002) Peripheral blood stem cell transplantation for POEMS syndrome. BONE MARROW TRANSPLANTATION , 30 (6) pp. 401-404. 10.1038/sj.bmt.1703670.

Peltékian, E; Garcia, L; Danos, O; (2002) Neurotropism and retrograde axonal transport of a canine adenoviral vector: a tool for targeting key structures undergoing neurodegenerative processes. Mol Ther , 5 (1) pp. 25-32. 10.1006/mthe.2001.0517.

Pemberton, PL; Down, JF; Porter, JB; Bromley, LM; (2002) A retrospective observational study of pre-operative sickle cell screening. ANAESTHESIA , 57 (4) 334 - 337.

Perera, D; Pizzey, A; Campbell, A; Katz, M; Porter, J; Petrou, M; Irvine, DS; (2002) Sperm DNA damage in potentially fertile homozygous beta-thalassaemia patients with iron overload. HUM REPROD , 17 (7) 1820 - 1825.

Perez, N; Plence, P; Millet, V; Greuet, D; Minot, C; Noel, D; Danos, O; (2002) Tetracycline transcriptional silencer tightly controls transgene expression after in vivo intramuscular electrotransfer: application to interleukin 10 therapy in experimental arthritis. Hum Gene Ther , 13 (18) pp. 2161-2172. 10.1089/104303402320987851.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; (2002) Further polymorphism of the MICA gene. EUR J IMMUNOGEN , 29 (1) pp. 35-46.

Perez-Rodriguez, M; Arguello, JR; Fischer, G; Corell, A; Cox, ST; Robinson, J; Hossain, E; (2002) Further polymorphism of the MICA gene. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (1) pp. 35-46. 10.1046/j.0960-7420.2001.00275.x.

Perez-Rodriguez, M; Madrigal, JA; Marsh, SGE; (2002) A novel HLA-DQA1 allele, DQA1*01042. TISSUE ANTIGENS , 59 (5) pp. 440-442. 10.1034/j.1399-0039.2002.590516.x.

Perez-Rodriguez, M; Raimondi, E; Marsh, SGE; Madrigal, JA; (2002) Identification of a new MICA allele, MICA*047. TISSUE ANTIGENS , 59 (3) pp. 216-218. 10.1034/j.1399-0039.2002.590306.x.

Perez-Simon, JA; Kottaridis, PD; Martino, R; Craddock, C; Caballero, D; Chopra, R; Garcia-Conde, J; (2002) Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders. BLOOD , 100 (9) 3121 - 3127. 10.1182/blood-2002-03-0701.

Peters, GJ; Backus, HHJ; Freemantle, S; van Triest, B; Codacci-Pisanelli, G; van der Wilt, CL; Smid, K; (2002) Induction of thymidylate synthase as a 5-fluorouracil resistance mechanism. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE , 1587 (2-3) 194 - 205.

Petrie, IA; Flynn, AA; Pedley, RB; Green, AJ; El-Emir, E; Dearling, JLJ; Boxer, GM; (2002) Spatial accuracy of 3D reconstructed radioluminographs of serial tissue sections and resultant absorbed dose estimates. PHYS MED BIOL , 47 (20) 3651 - 3661.

Pickard, D; Bigio, IJ; Bown, SG; Lovat, LB; Ripley, PM; Novelli, M; (2002) Optical biopsy for the diagnosis of dysplasia in Barrett's oesophagus. OPTICAL BIOPSY IV , 4613 234 - 243.

Pileri, SA; Ascani, S; Zinzani, PL; Gaidano, G; Piccioli, M; Rossi, M; Piccaluga, PP; (2002) Diffuse large B-cell lymphoma (DLBCL), anaplastic variant. report on a problematic case primarily arising in the stomach. Haematologica , 87 (12) ECR40-. Gold open access

Pileri, SA; Dirnhofer, S; Went, P; Ascani, S; Sabattini, E; Marafioti, T; Tzankov, A; (2002) Diffuse large B-cell lymphoma: one or more entities? Present controversies and possible tools for its subclassification. Histopathology , 41 (6) pp. 482-509.

Pileri, SA; Grogan, TM; Harris, NL; Banks, P; Campo, E; Chan, JK; Favera, RD; (2002) Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology , 41 (1) pp. 1-29.

Pinto, M; (2002) Induction and rejoining of DNA double-strand breaks in human cells after exposure to ionising radiation: an experimental and modelling approach. Doctoral thesis, University of London. Green open access
file

Platt, G; Carbone, A; Mittnacht, S; (2002) p16INK4a loss and sensitivity in KSHV associated primary effusion lymphoma. Oncogene , 21 (12) pp. 1823-1831. 10.1038/sj.onc.1205360.

Plemper, RK; Hammond, AL; Gerlier, D; Fielding, AK; Cattaneo, R; (2002) Strength of envelope protein interaction modulates cytopathicity of measles virus. JOURNAL OF VIROLOGY , 76 (10) pp. 5051-5061. 10.1128/JVI.76.10.5051-5061.2002.

Plummer, R; Ghielmini, M; Calvert, P; Voi, M; Renard, J; Gallant, G; Gupta, E; (2002) Phase I and pharmacokinetic study of the new taxane analog BMS-184476 given weekly in patients with advanced malignancies. CLIN CANCER RES , 8 (9) 2788 - 2797.

Porter, JB; Davis, BA; (2002) Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia. BEST PRACT RES CL HA , 15 (2) 329 - 368. 10.1053/beha.2002.0214.

Q

Quaglia, A; Dhillon, A; Godfrey, A; Laurent, C; Saini, J; Matull, R; Colombari, R; (2002) Degree of genomic heterogeneity correlates with a hepatocellular carcinoma (HCC) histological scoring system for HCC and putative precursor nodular lesions in cirrhotic livers. In: J HEPATOL. (pp. 217 - 218). ELSEVIER SCIENCE BV

Quaglia, A; Dhillon, A; Godfrey, A; Laurent, C; Saini, J; Matull, R; Colombari, R; (2002) Degree of genomic heterogeneity correlates with a hepatocellular carcinoma (HCC) histological scoring system for HCC and putative precursor nodular lesions in cirrhotic livers. Journal of Hepatology , 36 776-.

Quaglia, A; Laurent, C; Girlando, S; Saini, J; Dalla Palma, P; Colombari, R; Bioulac-Sage, P; (2002) Clonality and genomic heterogeneity in HCC and putative precursor nodular lesions. J HEPATOL , 36 83 - 83.

Quarmby, JW; Engelke, C; Chitolie, A; Morgan, RA; Belli, AM; (2002) Autologous thrombin for treatment of pseudoaneurysms. LANCET , 359 (9310) 946 - 947.

R

Radosavljevic, M; Cuillerier, B; Wilson, MJ; Clement, O; Wicker, S; Gilfillan, S; Beck, S; (2002) A cluster of ten novel MHC class I related genes on human chromosome 6q24.2-q25.3. GENOMICS , 79 (1) 114 - 123. 10.1006/geno.2001.6673.

Ramon, D; Corell, A; Cox, ST; Soteriou, B; Madrigal, JA; Marsh, SGE; (2002) Complete cDNA sequences of the HLA-DRB1*0402 and DRB1*11041 alleles. EUROPEAN JOURNAL OF IMMUNOGENETICS , 29 (5) pp. 453-455. 10.1046/j.1365-2370.2002.00354.x.

Reddy, A; Yuille, M; Sullivan, A; Repellin, C; Bell, A; Tidy, JA; Evans, DJ; (2002) Analysis of CHK2 in vulval neoplasia. Br J Cancer , 86 (5) pp. 756-760. 10.1038/sj.bjc.6600131.

Reid, AG; Huntly, BJP; Hennig, E; Niederwieser, D; Campbell, LJ; Bown, N; Telford, N; (2002) Deletions of the derivative chromosome 9 do not account for the poor prognosis associated with Philadelphia-positive acute lymphoblastic leukemia. In: BLOOD. (pp. 2274 - 2275). AMER SOC HEMATOLOGY

Rohn, JL; Zhang, YH; Aalbers, RI; Otto, N; Den Hertog, J; Henriquez, NV; Van De Velde, CJ; (2002) A tumor-specific kinase activity regulates the viral death protein Apoptin. J Biol Chem , 277 (52) pp. 50820-50827. 10.1074/jbc.M208557200. Gold open access

Rolfe, KJ; Crow, JC; Reid, WMN; Benjamin, E; MacLean, AB; Perrett, CW; (2002) The effect of topical corticosteroids on Ki67 and p53 expression in vulval lichen sclerosus. BRIT J DERMATOL , 147 (3) 503 - 508.

Rosti, G; Ferrante, P; Ledermann, J; Leyvraz, S; Ladenstein, R; Koscileniak, E; Crown, J; (2002) High-dose chemotherapy for solid tumors: results of the EBMT. Crit Rev Oncol Hematol , 41 (2) pp. 129-140.

Rowntree, C; Duke, V; Panayiotidis, P; Kotsi, P; Palmisano, GL; Hoffbrand, AV; Foroni, L; (2002) Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia. LEUKEMIA , 16 (7) pp. 1267-1275. 10.1038/sj.leu.2402551.

Rudnicka, AR; Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Influence of maternal smoking on the birth prevalence of Down syndrome and on second trimester screening performance. PRENATAL DIAG , 22 (10) 893 - 897. 10.1002/pd.440.

S

Sabin, CA; Emery, V; Devereux, HL; Griffioen, AA; Bishop, J; Dusheiko, G; Yee, TT; (2002) Long-term patterns of hepatitis C virus RNA concentrations in a cohort of HIV seronegative men with bleeding disorders. J MED VIROL , 68 (1) 68 - 75. 10.1002/jmv.10171.

Sabin, CA; Griffioen, A; Yee, TT; Emery, VC; Herrero-Martinez, E; Phillips, AN; Lee, CA; (2002) Markers of HIV-1 disease progression in individuals with haemophilia coinfected with hepatitis C virus: a longitudinal study. LANCET , 360 (9345) 1546 - 1551.

Salim, K; Fenton, T; Bacha, J; Urien-Rodriguez, H; Bonnert, T; Skynner, HA; Watts, E; (2002) Oligomerization of G-protein-coupled receptors shown by selective co-immunoprecipitation. J Biol Chem , 277 (18) pp. 15482-15485. 10.1074/jbc.M201539200.

Salomoni, P; Bernardi, R; Changuo, A; Tuttle, S; Pandolfi, PP; (2002) Nuclear dynamics of PML for c-Jun transcriptional regulation in response to DNA damage. In: BLOOD. (pp. 191A - 191A). AMER SOC HEMATOLOGY

Salomoni, P; Pandolfi, PP; (2002) p53 de-ubiquitination: at the edge between life and death. NAT CELL BIOL , 4 (6) E152 - E153. 10.1038/ncb0602-e152.

Salomoni, P; Pandolfi, PP; (2002) The role of PML in tumor suppression. CELL , 108 (2) 165 - 170.

Saunders, MI; Rojas, A; Lyn, BE; Wilson, E; Phillips, H; (2002) Dose-escalation with CHARTWEL (continuous hyperfractionated accelerated radiotherapy week-end less) combined with neo-adjuvant chemotherapy in the treatment of locally advanced non-small cell lung cancer. Clin Oncol (R Coll Radiol) , 14 (5) pp. 352-360.

Scheel-Toellner, D; Wang, K; Henriquez, NV; Webb, PR; Craddock, R; Pilling, D; Akbar, AN; (2002) Cytokine-mediated inhibition of apoptosis in non-transformed T cells and neutrophils can be dissociated from protein kinase B activation. Eur J Immunol , 32 (2) pp. 486-493. 10.1002/1521-4141(200202)32:2<486::AID-IMMU486>3.0.CO;2-U.

Schellens, JHM; Heinrich, B; Lehnert, M; Gore, ME; Kaye, SB; Dombernowsky, P; Paridaens, R; (2002) Population pharmacokinetic and dynamic analysis of the topoisomerase I inhibitor lurtotecan in phase II studies. INVEST NEW DRUG , 20 (1) 83 - 93.

Scheuer, PJ; Standish, RA; Dhillon, AP; (2002) Scoring of chronic hepatitis. Clin Liver Dis , 6 (2) 335-vi.

Serra, J; Sales, M; Chitolie, A; Domenech, P; Rossi, E; Borrell, M; Dahlback, B; (2002) Multicentre evaluation of IL Test (TM) Free PS: A fully automated assay to quantify Free Protein S. THROMB HAEMOSTASIS , 88 (6) 975 - 983.

Shah, FT; Westwood, MA; Evans, PJ; Porter, JB; (2002) Discordance in MRI assessment of iron distribution and plasma NTBI between transfusionally iron loaded adults with sickle cell and thalassaemia. In: BLOOD. (pp. 668A - 668A). AMER SOC HEMATOLOGY

Shams, PN; Waldman, A; Dogan, A; MacKenzie, JM; Plant, GT; (2002) Ataxia in the setting of complicated enteropathy: double jeopardy. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY , 72 (4) pp. 527-529.

Sharp, TV; Wang, HW; Koumi, A; Hollyman, D; Endo, Y; Ye, HT; Du, MQ; (2002) K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J VIROL , 76 (2) 802 - 816. 10.1128/JVI.76.2.802-816.2002.

Shaw, B; Mehta, AB; (2002) Pancytopenia responding to treatment of hyperthyroidism: a clinical case and review of the literature. Clin Lab Haematol , 24 (6) pp. 385-387.

Shing, DC; Morley-Jacob, CA; Roberts, I; Nacheva, E; Coleman, N; (2002) Ewing's tumour: novel recurrent chromosomal abnormalities demonstrated by molecular cytogenetic analysis of seven cell lines and one primary culture. In: (pp. pp. 20-27).

Sierens, J; Hartley, JA; Campbell, MJ; Leathem, AJC; Woodside, JV; (2002) In vitro isoflavone supplementation reduces hydrogen peroxide-induced DNA damage in sperm. TERATOGEN CARCIN MUT , 22 (3) 227 - 234. 10.1002/tcm.10015.

Simpson, AB; Calvert, PM; Sludden, JA; Boddy, AV; Griffin, MJ; Schatzlein, A; Wilson, P; (2002) Topotecan in combination with carboplatin: phase I trial evaluation of two treatment schedules. ANN ONCOL , 13 (3) 399 - 402. 10.1093/annonc/mdf041.

Sinclair, AM; Bench, AJ; Bloor, AJC; Gottgens, JLB; Stanley, ML; Miller, J; Piltz, S; (2002) Rescue of the lethal scl(-/-) phenotype by the human SCL locus. BLOOD , 99 (11) 3931 - 3938.

Southworth, R; Dearling, JLJ; Medina, RA; Flynn, AA; Pedley, RB; Garlick, PB; (2002) Dissociation of glucose tracer uptake and glucose transporter distribution in the regionally ischaemic isolated rat heart: application of a new autoradiographic technique. EUR J NUCL MED MOL I , 29 (10) 1334 - 1341. 10.1007/s00259-002-0922-2.

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; Hochhauser, D; (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. BLOOD , 100 (1) 224 - 229. Green open access
file

Spanswick, VJ; Craddock, C; Sekhar, M; Mahendra, P; Shankaranarayana, P; Hughes, RG; Hochhauser, D; (2002) Repair of DNA interstrand crosslinks as a mechanism of clinical resistance to melphalan in multiple myeloma. Blood , 100 (1) pp. 224-229.

Spencer, DI; Robson, L; Purdy, D; Whitelegg, NR; Michael, NP; Bhatia, J; Sharma, SK; (2002) A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics. Proteomics , 2 (3) pp. 271-279.

Spencer, DIR; Robson, L; Purdy, D; Whitelegg, NR; Michael, NP; Bhatia, J; Sharma, SK; (2002) A strategy for mapping and neutralizing conformational immunogenic sites on protein therapeutics. PROTEOMICS , 2 (3) 271 - 279.

Spender, LC; Cornish, GH; Sullivan, A; Farrell, PJ; (2002) Expression of transcription factor AML-2 (RUNX3, CBF(alpha)-3) is induced by Epstein-Barr virus EBNA-2 and correlates with the B-cell activation phenotype. J Virol , 76 (10) pp. 4919-4927.

Standish, R; Dhillon, A; Gibson, A; Jenkins, J; Difford, J; Savage, K; Atkins, M; (2002) The assessment of fibrosis in liver biopsies from patients with chronic HBV infection - Image analysis vs Ishak stage score. Journal of Hepatology , 36 986-.

Starke, R; Drummond, O; MacGregor, I; Biggerstaff, J; Gale, R; Camilleri, R; Mackie, I; (2002) The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? BRIT J HAEMATOL , 119 (3) 863 - 873.

Stein, RC; Zvelebil, MJ; (2002) The application of 2D gel-based proteomics methods to the study of breast cancer. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA , 7 (4) pp. 385-393. 10.1023/A:1024034031472.

Stephan, DA; Howell, GR; Teslovich, TM; Coffey, AJ; Smith, L; Bailey-Wilson, JE; Malechek, L; (2002) Physical and transcript map of the hereditary prostate cancer region at Xq27. GENOMICS , 79 (1) 41 - 50. 10.1006/geno.2001.6681.

Stoeber, K; Swinn, R; Prevost, AT; de Clive-Lowe, P; Halsall, I; Dilworth, SM; Marr, J; (2002) Diagnosis of genito-urinary tract cancer by detection of minichromosome maintenance 5 protein in urine sediments. J NATL CANCER I , 94 (14) 1071 - 1079.

Stubbs, M; Khan, K; Savage, K; Grimes, S; Michaeli, D; Dhillon, AP; Watson, S; (2002) Correlation between uptake of labelled anti-CCKB/gastrin receptor antibodies and the occurrence of apoptosis in hepatoma cell lines. GASTROENTEROLOGY , 122 (4) A380 - A380.

Stubbs, M; Khan, K; Savage, K; Grimes, S; Michaeli, D; Dhillon, AP; Watson, SA; (2002) Correlation between uptake of labelled anti-CCKB/gastrin receptor antibodies and the occurrence of apoptosis in hepatoma cell lines. Gut , 50 139-.

Stubbs, M; Khan, K; Savage, K; Grimes, S; Michaeli, D; Dhillon, AP; Watson, SA; (2002) Correlation between uptake of labelled anti-CCKB/gastrin receptor antibodies and the occurrence of apoptosis in hepatoma cell lines. GUT , 50 A39 - A39.

Stubbs, M; Khan, K; Watson, SA; Savage, K; Dhillon, AP; Caplin, ME; (2002) Endocytosis of anti-CCK-B/gastrin receptor antibody and effect on hepatoma cell lines. J HISTOCHEM CYTOCHEM , 50 (9) 1213 - 1217.

Sullivan, A; Yuille, M; Repellin, C; Reddy, A; Reelfs, O; Bell, A; Dunne, B; (2002) Concomitant inactivation of p53 and Chk2 in breast cancer. Oncogene , 21 (9) pp. 1316-1324. 10.1038/sj.onc.1205207.

T

Tamames, J; Clark, D; Herrero, J; Dopazo, J; Blaschke, C; Fernández, JM; Oliveros, JC; (2002) Bioinformatics methods for the analysis of expression arrays: data clustering and information extraction. J Biotechnol , 98 (2-3) pp. 269-283.

Tchilian, EZ; Dawes, R; Ramaley, PA; Whitworth, JA; Yuldasheva, N; Wells, RS; Watera, C; (2002) A CD45 polymorphism associated with abnormal splicing is absent in African populations. IMMUNOGENETICS , 53 (10-11) 980 - 983. 10.1007/s00251-001-0410-z.

Tedder, RS; Ayliffe, U; Preiser, W; Brink, NS; Grant, PR; Peggs, KS; Mackinnon, S; (2002) Development and evaluation of an internally controlled semiautomated PCR assay for quantification of cell-free cytomegalovirus. J MED VIROL , 66 (4) 518 - 523. 10.1002/jmv.2175.

Thomas, HD; Porter, DJ; Bartelink, I; Nobbs, JR; Cole, M; Elliott, S; Newell, DR; (2002) Randomized cross-over clinical trial to study potential pharmacokinetic interactions between cisplatin or carboplatin and etoposide. BRIT J CLIN PHARMACO , 53 (1) 83 - 91.

Tipping, AJ; Mahon, FX; Zafirides, G; Lagarde, V; Goldman, JM; Melo, JV; (2002) Drug responses of imatinib mesylate-resistant cells: synergism of imatinib with other chemotherapeutic drugs. LEUKEMIA , 16 (12) 2349 - 2357. 10.1038/sj.leu.2402775.

Tiwari, A; Hamilton, G; Seifalian, AM; Lowdell, MW; O'Neill, E; (2002) Regarding "Isolation of endothelial cells and their progenitor cells from human peripheral blood". J VASC SURG , 35 (4) 827 - 827. 10.1067/mva.2002.121064.

Toth, JL; Price, CA; Madsen, EC; Handl, HL; Hudson, SJ; Hubbard, RB; Bowen, JP; (2002) Sequence selective recognition of DNA by hairpin conjugates of a racemic seco-cyclopropaneindoline-2-benzofurancarboxamide and polyamides. Bioorg Med Chem Lett , 12 (16) pp. 2245-2248.

Tracey, L; Villuendas, R; Ortiz, P; Dopazo, A; Spiteri, I; Lombardia, L; Rodríguez-Peralto, JL; (2002) Identification of genes involved in resistance to interferon-alpha in cutaneous T-cell lymphoma. Am J Pathol , 161 (5) pp. 1825-1837.

Tsuzuki, S; Enver, T; (2002) Interactions of GATA-2 with the promyelocytic leukemia zinc finger (PLZF) protein, its homologue FAZF, and the t(11;17)-generated PLZF-retinoic acid receptor alpha oncoprotein. BLOOD , 99 (9) pp. 3404-3410. 10.1182/blood.V99.9.3404.

V

Vaidya, JS; Hall-Craggs, M; Baum, M; Tobias, JS; Falzon, M; D'Souza, DP; Morgan, S; (2002) Percutaneous minimally invasive stereotactic primary radiotherapy for breast cancer. LANCET ONCOL , 3 (4) 252 - 253.

Vassileva, V; Millar, A; Briollais, L; Chapman, W; Bapat, B; (2002) Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability. CANCER RESEARCH , 62 (14) pp. 4095-4099.

Vinall, LE; King, M; Novelli, M; Green, CA; Daniels, G; Hilkens, J; Sarner, M; (2002) Altered expression and allelic association of the hypervariable membrane mucin MUC1 in Helicobacter pylori gastritis. GASTROENTEROLOGY , 123 (1) 41 - 49. 10.1053/gast.2002.34157.

Virchis, A; Ganeshaguru, K; Hart, S; Jones, D; Fletcher, L; Wright, F; Wickremasinghe, R; (2002) A novel treatment approach for low grade lymphoproliferative disorders using PKC412 (CGP41251), an inhibitor of protein kinase C. Hematol J , 3 (3) pp. 131-136. 10.1038/sj.thj.6200165.

W

Wald, NJ; Hackshaw, AK; (2002) Folic acid supplementation and neural tube defects. AM J MED GENET , 109 (1) 79 - 79. 10.1002/ajmg.10292.

Wald, NJ; Huttly, W; Hackshaw, AK; (2002) Antenatal screening policies for Down's syndrome - Audit of Down's syndrome screening is not valid. BRIT MED J , 325 (7371) 1034 - 1034.

Wang, HW; Sharp, TV; Koumi, A; Koentges, G; Boshoff, C; (2002) Characterization of an anti-apoptotic glycoprotein encoded by Kaposi's sarcoma-associated herpesvirus which resembles a spliced variant of human survivin. EMBO J , 21 (11) 2602 - 2615.

Wanless, IR; Sweeney, G; Dhillon, AP; Guido, M; Piga, A; Galanello, R; Gamberini, MR; (2002) Lack of progressive hepatic fibrosis during long-term therapy with deferiprone in subjects with transfusion-dependent beta-thalassemia. BLOOD , 100 (5) 1566 - 1569. 10.1182/blood-2002-01-0306.

Ward, KN; White, RP; Mackinnon, S; Hanna, M; (2002) Human herpesvirus-7 infection of the CNS with acute myelitis in an adult bone marrow recipient. BONE MARROW TRANSPL , 30 (12) 983 - 985. 10.1038/sj.bmt.1703774.

Waterston, RH; Lindblad-Toh, K; Birney, E; Rogers, J; Abril, JF; Agarwal, P; Agarwala, R; (2002) Initial sequencing and comparative analysis of the mouse genome. NATURE , 420 (6915) 520 - 562. 10.1038/nature01262.

Watts, MJ; Somervaille, TC; Ings, SJ; Ahmed, F; Khwaja, A; Yong, K; Linch, DC; (2002) Variable product purity and functional capacity after CD34 selection: a direct comparison of the CliniMACS (v2.1) and Isolex 300i (v2.5) clinical scale devices. Br J Haematol , 118 (1) pp. 117-123.

Westerman, MP; Pizzey, A; Wiener-Well, Y; Ramotar, H; Lawrie, A; Purdy, G; Mackie, I; (2002) Circulating red cell-derived vesicles expressing phosphatidylserine are increased in thalassemia as well as in sickle cell disorders. In: BLOOD. (pp. 237A - 237A). AMER SOC HEMATOLOGY

Westin, J; Lagging, LM; Spak, F; Aires, N; Svensson, E; Lindh, M; Dhillon, AP; (2002) Moderate alcohol intake increases fibrosis progression in untreated patients with hepatitis C virus infection. J VIRAL HEPATITIS , 9 (3) 235 - 241.

Whelan, JS; Burcombe, RJ; Janinis, J; Baldelli, AM; Cassoni, AM; (2002) A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol , 13 (1) pp. 23-30.

Wilkinson, J; Cope, A; Gill, J; Bourboulia, D; Hayes, P; Imami, N; Kubo, T; (2002) Identification of Kaposi's sarcoma-associated herpesvirus (KSHV)-specific cytotoxic T-lymphocyte epitopes and evaluation of reconstitution of KSHV-specific responses in human immunodeficiency virus type 1-infected patients receiving highly active antiretroviral therapy. J VIROL , 76 (6) 2634 - 2640. 10.1128/JVI.76.6.2634-2640.2002.

Woo, YL; Allard, S; Cohen, H; Letsky, E; de Swiet, M; (2002) Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia. BJOG-INT J OBSTET GY , 109 (4) 466 - 468.

Y

Yaguchi, H; Ohkura, N; Tsukada, T; Yamaguchi, K; (2002) Menin, the multiple endocrine neoplasia type 1 gene product, exhibits GTP-hydrolyzing activity in the presence of the tumor metastasis suppressor nm23. J Biol Chem , 277 (41) pp. 38197-38204. 10.1074/jbc.M204132200. Gold open access

Yates, F; Malassis-Séris, M; Stockholm, D; Bouneaud, C; Larousserie, F; Noguiez-Hellin, P; Danos, O; (2002) Gene therapy of RAG-2-/- mice: sustained correction of the immunodeficiency. Blood , 100 (12) pp. 3942-3949. 10.1182/blood-2002-03-0782.

Yee, TT; Beeton, K; Griffioen, A; Harrington, C; Miners, A; Lee, CA; Brown, SA; (2002) Experience of prophylaxis treatment in children with severe haemophilia. HAEMOPHILIA , 8 (2) 76 - 82.

Yong, KL; Fahey, A; Pahal, G; Linch, DC; Pizzey, A; Thomas, NSB; Jauniaux, E; (2002) Fetal haemopoietic cells display enhanced migration across endothelium. BRIT J HAEMATOL , 116 (2) 392 - 400.

Yong, KL; Fahey, A; Pizzey, A; Linch, DC; (2002) Influence of cell cycling and cell division on transendothelial migration of CD34(+) cells. BRIT J HAEMATOL , 119 (2) 500 - 509.

Z

Zehnder, D; Bland, R; Chana, RS; Wheeler, DC; Howie, AJ; Williams, MC; Stewart, PM; (2002) Synthesis of 1,25-dihydroxyvitamin D-3 by human endothelial cells is regulated by inflammatory cytokines: A novel autocrine determinant of vascular cell adhesion. J AM SOC NEPHROL , 13 (3) ? - ?.

Zhang, J; Vanhaesebroeck, B; Rittenhouse, SE; (2002) Human platelets contain p110 delta phosphoinositide 3-kinase. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS , 296 (1) pp. 178-181. 10.1016/S0006-291X(02)00744-1.

Zhyvoloup, A; Nemazanyy, I; Babich, A; Panasyuk, G; Pobigailo, N; Vudmaska, M; Naidenov, V; (2002) Molecular cloning of CoA synthase - The missing link in CoA biosynthesis. J BIOL CHEM , 277 (25) 22107 - 22110. 10.1074/jbc.C200195200. Gold open access

Zong, JC; Ciufo, DM; Viscidi, R; Alagiozoglou, L; Tyring, S; Rady, P; Orenstein, J; (2002) Genotypic analysis at multiple loci across Kaposi's sarcoma herpesvirus (KSHV) DNA molecules: clustering patterns, novel variants and chimerism. J CLIN VIROL , 23 (3) 119 - 148.

This list was generated on Sun Dec 4 06:32:09 2016 GMT.